Screening of inFlammation to enable personalized Medicine
Together we reach the next level of diagnostics
Millions of people in the European Union (EU) suffer from diseases associated with dysregulation of the complement system, which is a major component of the immune system
approximately 3,300 new cases of bacterial infections such as invasive meningococcal disease are diagnosed p.a. in infants and young children in the EU
about 200,000 young adults in Europe suffer from chronic inflammation of the kidney
and 15 million elderly European residents are affected by limited vision due to age-related macular degeneration.
1) investigate the pathophysiology of the FH-protein family, to enable
2) the development of personalized, radically new on-time diagnostics, which allow
3) improved patient stratification for prospective cohort studies to
understand complement-associated diseases.
This multi-disciplinary project will combine fundamental immunological research with novel nanomaterial-based biosensor development translated into proof-of-principle diagnostics to revolutionize doctors’ ability to diagnose and treat severe inflammatory diseases plaguing millions of Europeans.